Lu; Yong-Chen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lu; Yong-Chen.The latest application filed is for "anti-kras-g12d t cell receptors".

Company Profile

11.4.13

Lu; Yong-Chen - Rockville MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-kras-g12d T Cell Receptors App 20220089677 - Tran; Eric ; et al.	2022-03-24
Anti-KRAS-.sup.G12D T cell receptors Grant 11,208,456 - Tran , et al. December 28, 2	2021-12-28
Anti-kras-g12d T Cell Receptors App 20210300988 - Tran; Eric ; et al.	2021-09-30
Methods Of Isolating T Cells Having Antigenic Specificity For A Cancer-specific Mutation App 20210220457 - Tran; Eric ; et al.	2021-07-22
Methods of isolating T cells having antigenic specificity for a cancer-specific mutation Grant 10,973,894 - Tran , et al. April 13, 2	2021-04-13
Hla Class I-restricted T Cell Receptors Against Mutated Ras App 20210079058 - Yoseph; Rami ; et al.	2021-03-18
T Cell Receptors Recognizing Mutated P53 App 20200277352 - Deniger; Drew C. ; et al.	2020-09-03
Anti-kras-g12d T Cell Receptors App 20200247869 - Kind Code	2020-08-06
T Cell Receptors Recognizing Hla-cw8 Restricted Mutated Kras App 20200148739 - Tran; Eric ; et al.	2020-05-14
Anti-KRAS-G12D T cell receptors Grant 10,611,816 - Tran , et al.	2020-04-07
Methods Of Isolating Neoantigen-specific T Cell Receptor Sequences App 20200056237 - Lu; Yong-Chen ; et al.	2020-02-20
T cell receptors recognizing HLA-Cw8 restricted mutated KRAS Grant 10,556,940 - Tran , et al. Feb	2020-02-11
Anti-kras-g12d T Cell Receptors App 20190177395 - Tran; Eric ; et al.	2019-06-13
T Cell Receptors Recognizing Hla-cw8 Restricted Mutated Kras App 20190040111 - Tran; Eric ; et al.	2019-02-07
Methods Of Isolating T Cells Having Antigenic Specificity For A Cancer-specific Mutation App 20170224800 - Tran; Eric ; et al.	2017-08-10
Methods Of Isolating T Cell Receptors Having Antigenic Specificity For A Cancer-specific Mutation App 20170218042 - Tran; Eric ; et al.	2017-08-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.